Vendor, Beltsville, MD
Reprocell U.S.A., Inc.
UEI F1KBMX8JQ385, CAGE 1L6R9
2 awards and $64,314 obligated between June 22, 2026 and July 7, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $32,266 |
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $32,048 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Competed Under SAP | 1 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N98026P00965Purchase Order, July 7, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health OlaoNational Institutes of Health | Niaaa: 1. 124 Paxgene TubesNAICS 541714, PSC Q301 | $32,266 |
| 75N98026P00843Purchase Order, June 22, 2026, Competed Under SAP, 1 offers | National Institutes of Health OlaoNational Institutes of Health | Catalog# RNA150. 50 Patients, Each with Three Paxgene Tubes, Rna Extraction, Quantitation, Normalization Agilent QC and Aliquoting Up to 21 NAICS 325414, PSC 6505 | $32,048 |
- Places of performance
- Maryland
- Product and service codes
- Q301 Reference Laboratory Testing6505 Drugs and Biologicals
- Transactions
- 2 across 2 awards